Patent details

Basic Information

Publication number:

EP3720879

PCT Application Number:

EP2018083651

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP188297428

PCT Publication Number:

WO2019110662

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

COMBINATION THERAPY BETWEEN ANTI-PROGASTRIN ANTIBODY AND IMMUNOTHERAPY TO TREAT CANCER

French Title of Invention:

THÉRAPIE DE COMBINAISON COMPRENANT DES ANTICORPS ANTI-PROSTAGLANDINE ET IMMUNOTHÉRAPIE POUR TRAITER CANCER

German Title of Invention:

KOMBINATIONSTHERAPIE AUS ANTI-PROGASTRIN ANTIKÖRPERN UND IMMUNTHERAPIE ZUR KREBSBEHANDLUNG

SPC Number:

Dates

Filing date:

05/12/2018

Grant date:

11/05/2022

EP Publication Date:

14/10/2020

PCT Publication Date:

13/06/2019

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

11/05/2022

EP B1 Publication Date:

11/05/2022

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

05/12/2022

Expiration date:

05/12/2038

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

04/05/2022

 

 

Name:

Progastrine et Cancers S.à r.l.

Address:

11, Côte d'Eich, 1450 Luxembourg, Luxembourg (LU)

Inventor

Name:

PRIEUR, Alexandre

Address:

France (FR)

Priority

Priority Number:

201762594755 P

Priority Date:

05/12/2017

Priority Country:

United States (US)

Classification

IPC classification:

C07K 16/26; C07K 16/28; A61K 39/395;

Publication

European Patent Bulletin

Issue number:

202219

Publication date:

11/05/2022

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages